Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rituximab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rituximab 100mg/10ml solution for infusion vials
0802030F0AAABAB
|
Rituximab | Rituximab | Malignant Disease and Immunosuppression | 1 |
|
Ituxredi 100mg/10ml concentrate for inf vials
0802030F0BFABAB
|
Ituxredi | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Ituxredi 500mg/50ml concentrate for inf vials
0802030F0BFAAAA
|
Ituxredi | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
MabThera 100mg/10ml concentrate for inf vials
0802030F0BBABAB
|
MabThera | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
MabThera 1400mg/11.7ml solution for injection vials
0802030F0BBACAC
|
MabThera | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
MabThera 500mg/50ml concentrate for inf vials
0802030F0BBAAAA
|
MabThera | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Rituximab 1.4g/11.7ml solution for injection vials
0802030F0AAACAC
|
Rituximab | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Rituximab 500mg/50ml solution for infusion vials
0802030F0AAAAAA
|
Rituximab | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Rixathon 100mg/10ml concentrate for inf vials
0802030F0BDAAAB
|
Rixathon | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Rixathon 500mg/50ml concentrate for inf vials
0802030F0BDABAA
|
Rixathon | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Ruxience 100mg/10ml concentrate for inf vials
0802030F0BEACAB
|
Ruxience | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Ruxience 500mg/50ml concentrate for inf vials
0802030F0BEABAA
|
Ruxience | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Truxima 100mg/10ml concentrate for inf vials
0802030F0BCABAB
|
Truxima | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Truxima 500mg/50ml concentrate for inf vials
0802030F0BCAAAA
|
Truxima | Rituximab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.